インドの医薬品受託販売機関の市場規模は、2023年に3億980万ドルと推定され、2024年から2030年にかけて7.9%のCAGRで成長すると予測されます。医薬品のアウトソーシング傾向の高まり、製薬業界の複雑化、営業力の有効性の向上が、今後数年間に市場の成長を促進すると予想される重要な要因です。医薬品の受託販売アウトソーシング企業は、厳しい規制基準によって規制されている業界でコンプライアンスを優先しています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. End-use
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in India
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Service outlook
2.2.2. End Use outlook
2.3. Competitive Insights
Chapter 3. India Pharmaceutical Contract Sales Organizations Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing pharmaceutical outsourcing trends
3.2.1.2. Increased pharmaceutical industry complexity
3.2.1.3. Enhanced sales force effectiveness
3.2.2. Market restraint analysis
3.2.2.1. Data security and privacy concerns
3.2.2.2. Dependency on client companies
3.3. India Pharmaceutical Contract Sales Organizations Market Analysis Tools
3.3.1. Industry analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. India Pharmaceutical Contract Sales Organizations Market: Service Business Analysis
4.1. India Pharmaceutical Contract Sales Organizations Market, By Service: Segment Dashboard
4.2. India Pharmaceutical Contract Sales Organizations Market, By Service: Movement Analysis
4.3. India Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts, By Service, 2018 - 2030
4.3.1. Personal Promotion
4.3.1.1. India Personal Promotion Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.1.2. Promotional Sales Team
4.3.1.2.1 India Promotional Sales Team Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.1.3. Key Account Management
4.3.1.3.1 India Key Account Management Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.1.4. Vacancy Management
4.3.1.4.1 India Vacancy Management Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.2. Non-personal Promotion
4.3.2.1. India Non-personal Promotion Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.2.2. Medical Affairs Solutions
4.3.2.2.1 India Medical Affairs Solutions Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.2.3. Remote Medical Science Liaisons
4.3.2.3.1. India Remote Medical Science Liaisons Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.2.4. Nurse (Clinical) Educators
4.3.2.4.1. India Nurse (Clinical) Educators Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.2.5. Others
4.3.2.5.1. India Others Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
Chapter 5. India Pharmaceutical Contract Sales Organizations Market: End-use Business Analysis
5.1. India Pharmaceutical Contract Sales Organizations Market, By End-use: Segment Dashboard
5.2. India Pharmaceutical Contract Sales Organizations Market, By End-use: Movement Analysis
5.3. India Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts, By End-use, 2018 - 2030
5.3.1. Pharmaceutical Companies
5.3.1.1. India Pharmaceutical Companies Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
5.3.2. Biopharmaceutical Companies
5.3.2.1. India Biopharmaceutical Companies Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Heat Map Analysis
6.3. Company Categorization
6.4. Strategy Mapping
6.4.1. Merger& Acquisition
6.4.2. Collaborations
6.4.3. New Product Launch
6.5. Participant’s overview
6.5.1. IQVIA Inc.
6.5.1.1. Overview
6.5.1.2. Financial Performance
6.5.1.3. Product Benchmarking
6.5.1.4. Strategic Initiatives
6.5.2. Syneos Health
6.5.2.1. Overview
6.5.2.2. Financial Performance
6.5.2.3. Product Benchmarking
6.5.2.4. Strategic Initiatives
6.5.3. Parexel International (MA) Corporation
6.5.3.1. Overview
6.5.3.2. Financial Performance
6.5.3.3. Product Benchmarking
6.5.3.4. Strategic Initiatives
6.5.4. Mednext Pharma Private Limited
6.5.4.1. Overview
6.5.4.2. Financial Performance
6.5.4.3. Product Benchmarking
6.5.4.4. Strategic Initiatives
6.5.5. Indegene
6.5.5.1. Overview
6.5.5.2. Financial Performance
6.5.5.3. Product Benchmarking
6.5.5.4. Strategic Initiatives
6.5.6. ICON plc
6.5.6.1. Overview
6.5.6.2. Financial Performance
6.5.6.3. Product Benchmarking
6.5.6.4. Strategic Initiatives
6.5.7. PPD (Thermo Fisher Scientific Inc.)
6.5.7.1. Overview
6.5.7.2. Financial Performance
6.5.7.3. Product Benchmarking
6.5.7.4. Strategic Initiatives
6.5.8. QFR Solutions
6.5.8.1. Overview
6.5.8.2. Financial Performance
6.5.8.3. Product Benchmarking
6.5.8.4. Strategic Initiatives
6.5.9. LabCorp
6.5.9.1. Overview
6.5.9.2. Financial Performance
6.5.9.3. Product Benchmarking
6.5.9.4. Strategic Initiatives
6.5.10. Makrocare
6.5.10.1. Overview
6.5.10.2. Financial Performance
6.5.10.3. Product Benchmarking
6.5.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 India Pharmaceutical Contract Sales Organizations Market by Service, 2018 - 2030 (USD Million)
Table 4 India Pharmaceutical Contract Sales Organizations Market by End-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Pharmaceutical Contract Sales Organizations Market, Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 10 Penetration & Growth Prospect Mapping
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 14 Regional Marketplace: Key Takeaways
Fig. 15 India Pharmaceutical Contract Sales Organizations Market for Personal Promotion, 2018 - 2030 (USD Million)
Fig. 16 India Pharmaceutical Contract Sales Organizations Market for Promotional sales team, 2018 - 2030 (USD Million)
Fig. 17 India Pharmaceutical Contract Sales Organizations Market for Key account management, 2018 - 2030 (USD Million)
Fig. 18 India Pharmaceutical Contract Sales Organizations Market for Vacancy Management, 2018 - 2030 (USD Million)
Fig. 19 India Pharmaceutical Contract Sales Organizations Market for Non-personal promotion, 2018 - 2030 (USD Million)
Fig. 20 India Pharmaceutical Contract Sales Organizations Market for Medical affairs solutions, 2018 - 2030 (USD Million)
Fig. 21 India Pharmaceutical Contract Sales Organizations Market for Remote medical science liaisons, 2018 - 2030 (USD Million)
Fig. 22 India Pharmaceutical Contract Sales Organizations Market for Nurse (clinical) educators, 2018 - 2030 (USD Million)
Fig. 23 India Pharmaceutical Contract Sales Organizations Market for Others, 2018 - 2030 (USD Million)
Fig. 24 India Pharmaceutical Contract Sales Organizations Market for Pharmaceutical companies, 2018 - 2030 (USD Million)
Fig. 25 India Pharmaceutical Contract Sales Organizations Market for Biopharmaceutical companies, 2018 - 2030 (USD Million)
